Communiqués MediPal Holdings Corporation

Actions

7459

JP3268950007

Temps Différé Japan Exchange Autres places de cotation 08:00:00 04/06/2024			Varia. 5j.	Varia. 1 janv.
2 352 ^JPY	+0,13 %		+4,93 %	+2,89 %

31/05	MediPal Holdings Corporation (TSE:7459) a conclu l'acquisition de PreMedica Inc. auprès de Noritsu Koki Co., Ltd. (TSE:7744).	CI
14/05	MediPal Holdings Corporation (TSE:7459) annonce un rachat d'actions pour 2.500.000 actions, représentant 1,19%, pour un montant de 5.000 millions ¥.	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

MediPal : Notice Regarding Progress of Acquisition of Treasury Stock	08:07	PU
MediPal : Selected for the First Time as a Component of the "MSCI Japan ESG Select Leaders Index"	21/05	PU
MediPal : Notice Regarding Decision on Matters Concerning Acquisition of Treasury Stock and Cancellation of Treasury Stock	14/05	PU
MediPal : Notice of Acquisition of Shares in PreMedica Inc.	30/04	PU
MediPal : Notice of Investment in MNES Inc. through MEDIPAL Innovation Fund	30/04	PU
MediPal : Notice of Basic Agreement concerning Integration between Consolidated Subsidiaries	02/11	PU
MediPal : Notice Regarding Progress of Acquisition of Treasury Stock	02/11	PU
Sumitomo Pharma Announces Completion of Share Transfer of Consolidated Subsidiary, Sumitomo Pharma Food and Chemical	03/04/23	AQ
Sumitomo Pharma Announces Transfer of Shares of a Consolidated Subsidiary, Sumitomo Pharma Food & Chemical	01/12/22	AQ
MediPal : Integrated Report 2020	27/06/22	PU
Cryoport : MEDIPAL HOLDINGS Partners with CRYOPORT to Bring Temperature-Controlled Supply Chain Solutions to the Japanese Market	05/08/20	AQ
Medipal : Notice of Revision of Year-End Dividend Forecast	27/04/18	PU
Medipal : JCR and MEDIPAL to Establish Joint Venture Company in U.S.	19/12/17	PU
MEDIPAL : and JCR Pharmaceuticals Co., Ltd. Strengthen Business and Capital Alliance	26/09/17	PU
Medipal : Summary of Consolidated Financial Statements for the First Quarter of the Fiscal Year Ending March 31, 2018	09/08/17	PU
Medipal : Notice of Amounts of Assets and Liabilities Transferred from Consolidated Subsidiary through Absorption-type Demerger and Extraordinary Gain in Non-Consolidated Results	19/05/17	PU
Medipal : Notice of Revision of Year-End Dividend Forecast	28/04/17	PU
Medipal : Notice of Transfer of Subsidiary Business by Demerger (Simple Absorption-type Demerger)	20/02/17	PU
Medipal : Summary of Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2017	14/02/17	PU
Medipal : Notice of Differences between Forecast of Financial Results and Actual Results for the Interim Period of the Fiscal Year Ending March 31, 2017, Revisions to Forecast of Financial Results for the Fiscal Year Ending March 31, 2017, and Dividends and Revisions to Dividend Forecast (Dividend Increase) at Consolidated Subsidiary PALTAC CORPORATION	15/11/16	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués MediPal Holdings Corporation

Actions

7459

JP3268950007

Communiqués

Filtres